Last reviewed · How we verify
Sickling disorder due to hemoglobin S
Approved treatments
- Hydroxycarbamide · University of Birmingham
- Siklos · Theravia
- Xromi · Nova Laboratories Limited
- Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Sickling disorder due to hemoglobin S patent landscape — cliff calendar, originator estates, attackable patents
- Sickling disorder due to hemoglobin S treatment landscape brief
- Sickling disorder due to hemoglobin S treatment updates RSS
Frequently asked questions about Sickling disorder due to hemoglobin S
What drugs treat Sickling disorder due to hemoglobin S?
Tracked treatments include Hydroxycarbamide, Siklos, Xromi, Hydroxycarbamid.
What is the treatment for Sickling disorder due to hemoglobin S?
Standard treatment for Sickling disorder due to hemoglobin S includes Hydroxycarbamide, Siklos, Xromi, Hydroxycarbamid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Sickling disorder due to hemoglobin S patent cliff · Sickling disorder due to hemoglobin S CI report
- Treatment: Hydroxycarbamide · University of Birmingham
- Treatment: Siklos · Theravia
- Treatment: Xromi · Nova Laboratories Limited
- Treatment: Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing